Edulis Therapeutics Inc.

Carnegie Mellon University

A topical drug delivery system for Crohn’s Disease. Our endoscopically-deployed, bioresorbable patch will non-invasively anchor itself at the area of inflammation and slowly release generic anti-inflammatory medication over a 12-month period.